Reduced Brain Cannabinoid Receptor Availability In Schizophrenia

BACKGROUND: Several lines of evidence suggest the presence of abnormalities in the endocannabinoid (eCB) system in schizophrenia (SCZ). However, there are limited in vivo measures of the eCB system in SCZ. METHODS: Twenty five male SCZ subjects (SCZs), 18 antipsychotic treated [SCZ-MED] and 7 antips...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Psychiatry
Hlavní autoři: Ranganathan, Mohini, Cortes, Jose, Radhakrishnan, Rajiv, Thurnauer, Halle, Planeta, Beata, Skosnik, Patrick, Gao, Hong, Labaree, David, Neumeister, Alexander, Pittman, Brian, Surti, Toral, Huang, Yiyun, Carson, Richard E., D’Souza, Deepak Cyril
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
https://ncbi.nlm.nih.gov/pubmed/26432420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2015.08.021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky